Karma Oncology is coming up to a very busy quarter! Karma Oncology will again be travelling all over the world to attend all the Big BIO Events for the end of the year including BIOPHARMA AMERICA BIO JAPAN and BIO-EUROPE. Will you be there? Contact our Business Development Manager Dr Kara Kennedy (firstname.lastname@example.org) to catch
Cancer – it is one of the world’s most pressing healthcare challenges and something that most of us have some form of a connection with at some-point throughout our lifetime. We are living in a dynamic moment in time for oncology treatment where 2018 brings us many clinical advancements for the treatment options for Cancer.
CAR-T cell therapy has been able to effectively treat cancer in some patients for whom all other treatment options were exhausted. However, the technology still has a long road ahead before becoming a widespread treatment option. Read this insightful interview with Christian CEO of Celyad. Read More Here: https://labiotech.eu/car-t-cell-therapy-cancer-celyad/
Karma Oncology are always keeping up to date with the latest Biotech news and treatments on the market. We attend many events each year and always make sure we attend ASCO -the biggest oncology conference in the world. Here is a link to the highlights of the event. https://labiotech-eu.cdn.ampproject.org/c/s/labiotech.eu/european-cancer-research-asco-2018/amp/
The novel immunotherapy that is CAR-T seems to be the hot topic of the oncology market and has held it’s place there for quite some time. However, there are major safety issues when it comes to this immuno-oncology therapy. This article gives some insights into how scientists are trying to understand and overcome the safety
Link to an interesting article posted by The Scientist on how sex can implement the effectiveness of Immunotherapy in Cancer. Interesting Read! Link below: https://www.the-scientist.com/?articles.amp/articleNo/54614/title/Immunotherapy-More-Effective-in-Men–Study/&__twitter_impression=true/
Thanks to Cytel here is an insight into what to expect from the fantastic line up at #ASCO from the likes of Cell Medica. http://bit.ly/2rX2XpQ
As the GDPR deadline approaches we cannot forget how important Cybersecurity is. It is important to protect your company and your patients from Cyber criminals. This article from Fierce Biotech highlights the vulnerability that can occur when using medical devices. https://www.fiercebiotech.com/medtech/dhs-warns-cybersecurity-weakness-medtronic-s-neurostimulator-programmer?mkt_tok=eyJpIjoiTnpRMFltUTJZemM0TURrdyIsInQiOiI4K1VDNmUySEFQRzE3SzZQNEd4bENIc2hBUWpaUkZFTmpUVkZnUzQ5QzlvSFZ0N0h4YzZHQUhXXC9xQmhyWHNcL1lVeW9nbTRSekI5WWlrKzhkSUNYcTFUMjNiU3FPVWUyV091VUhqR05RVFd0bm9aV0E1QVZOaGQ2XC8yV0lsT3IyeSJ9&mrkid=64593462
Great article from Springer Nature on the current CAR-T therapies in development. https://lnkd.in/g6r-CRH Do you know Karma Oncology has experience in CAR-T and autologous therapy? Meet us at #ASCO or #BIO to find out more!